MEI Pharma, Inc.
General ticker "MEIP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.6M (TTM average)
MEI Pharma, Inc. follows the US Stock Market performance with the rate: 33.0%.
Estimated limits based on current volatility of 2.9%: low 2.52$, high 2.74$
Factors to consider:
- Total employees count: 28 (-31.7%) as of 2024
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [2.01$, 4.97$]
- 2025-06-30 to 2026-06-30 estimated range: [2.33$, 5.43$]
Financial Metrics affecting the MEIP estimates:
- Positive: with PPE of 0.7 at the end of fiscal year the price was very low
- Negative: Operating cash flow per share per price, % of -264.66 <= 0.85
- Positive: Operating profit margin, % of 22.27 > 18.38
- Positive: Return on assets ratio (scaled to [-100,100]) of 30.05 > 6.25
- Negative: Industry operating cash flow per share per price (median), % of -25.72 <= 2.35
- Positive: Shareholder equity ratio, % of 79.81 > 62.86
Short-term MEIP quotes
Long-term MEIP plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $48.82MM | $65.30MM | $0.00MM |
| Operating Expenses | $85.58MM | $50.76MM | $17.45MM |
| Operating Income | $-36.76MM | $14.54MM | $-17.45MM |
| Non-Operating Income | $4.93MM | $3.24MM | $1.51MM |
| R&D Expense | $52.45MM | $16.56MM | $3.92MM |
| Income(Loss) | $-31.84MM | $17.78MM | $-15.95MM |
| Profit(Loss)* | $-31.84MM | $17.78MM | $-15.95MM |
| Stockholders Equity | $24.62MM | $33.02MM | $16.93MM |
| Assets | $120.81MM | $41.38MM | $18.29MM |
| Operating Cash Flow | $-52.48MM | $-50.47MM | $-20.84MM |
| Capital expenditure | $0.04MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $53.69MM | $49.14MM | $35.15MM |
| Financing Cash Flow | $-0.04MM | $-11.87MM | $0.00MM |
| Earnings Per Share** | $-4.78 | $2.67 | $-2.39 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.